Suppr超能文献

从青藤仔中分离得到的新型血管α-肾上腺素能受体和5-羟色胺受体拮抗剂(-)-地离散明的药理活性。

Pharmacological activity of (-)-discretamine, a novel vascular alpha-adrenoceptor and 5-hydroxytryptamine receptor antagonist, isolated from Fissistigma glaucescens.

作者信息

Ko F N, Yu S M, Su M J, Wu Y C, Teng C M

机构信息

Pharmacological Institute, College of Medicine, National Taiwan University, Taipei.

出版信息

Br J Pharmacol. 1993 Oct;110(2):882-8. doi: 10.1111/j.1476-5381.1993.tb13895.x.

Abstract
  1. The pharmacological activity of (-)-discretamine, isolated from Fissistigma glaucescens, was determined in rat isolated thoracic aorta, cardiac tissues and ventricular myocytes and guinea-pig isolated trachea. 2. (-)-Discretamine was found to be an alpha 1-adrenoceptor blocking agent in rat thoracic aorta as revealed by its competitive antagonism of noradrenaline (pA2 = 7.20 +/- 0.10)- or phenylephrine (pA2 = 7.60 +/- 0.09)-induced vasoconstriction. It was as potent as phentolamine (pA2 = 7.51 +/- 0.10), but was more potent than yohimbine (pA2 = 6.18 +/- 0.06). Removal of endothelium significantly increased the antagonistic potency of (-)-discretamine on noradrenaline (pA2 = 7.52 +/- 0.09)- or phenylephrine (pA2 = 7.90 +/- 0.09)-induced vasoconstriction. 3. (-)-Discretamine was also an alpha 2-adrenoceptor blocking agent (pA2 = 6.30 +/- 0.15) and a 5-hydroxytryptamine antagonist (pA2 = 6.87 +/- 0.06), both in rat aorta denuded of endothelium. 4. (-)-Discretamine protected alpha-adrenoceptors from alkylation by the irreversible blocking agent, phenoxybenzamine. 5. [3H]-inositol monophosphate formation caused by noradrenaline (3 microM) in rat thoracic aorta was suppressed by (-)-discretamine (10 and 30 microM) and prazosin (3 microM). 6. A high concentration of (-)-discretamine (30 microM) did not affect the contraction induced by the thromboxane receptor agonist U-46619, prostaglandin F2 alpha (PGF2 alpha), angiotensin II, high K+ or endothelin in rat aorta denuded of endothelium. Neither cyclic AMP nor cyclic GMP content of rat thoracic aorta was changed by (-)-discretamine. 7. Contraction of guinea-pig trachea caused by histamine, leukotriene C4 or carbachol was not affected by (-)-discretamine (30 microM). (-)-Discretamine also did not block beta l- or beta2-adrenoceptor-mediated responses induced by isoprenaline in rat right atria and guinea-pig trachea.8. A voltage clamp study in rat ventricular single myocytes revealed that sodium inward current, slow inward Ca2+ current or transient (ItO) and steady state (I800) outward current was not affected by(-)-discretamine (30 microM).9. It is concluded that (-)-discretamine is a selective x-adrenoceptor and 5-HT receptor antagonist in vascular smooth muscle.
摘要
  1. 从青藤仔中分离得到的(-)-地离散明的药理活性,在大鼠离体胸主动脉、心脏组织和心室肌细胞以及豚鼠离体气管中进行了测定。2. (-)-地离散明在大鼠胸主动脉中被发现是一种α1-肾上腺素能受体阻断剂,这可通过其对去甲肾上腺素(pA2 = 7.20±0.10)或苯肾上腺素(pA2 = 7.60±0.09)诱导的血管收缩的竞争性拮抗作用得以揭示。它与酚妥拉明(pA2 = 7.51±0.10)的效力相当,但比育亨宾(pA2 = 6.18±0.06)更有效。去除内皮显著增加了(-)-地离散明对去甲肾上腺素(pA2 = 7.52±0.09)或苯肾上腺素(pA2 = 7.90±0.09)诱导的血管收缩的拮抗效力。3. (-)-地离散明在去内皮的大鼠主动脉中也是一种α2-肾上腺素能受体阻断剂(pA2 = 6.30±0.15)和5-羟色胺拮抗剂(pA2 = 6.87±0.06)。4. (-)-地离散明可保护α-肾上腺素能受体免受不可逆阻断剂苯氧苄胺的烷基化作用。5. (-)-地离散明(10和30μM)和哌唑嗪(3μM)可抑制去甲肾上腺素(3μM)在大鼠胸主动脉中引起的[3H]-肌醇单磷酸形成。6. 高浓度的(-)-地离散明(30μM)不影响血栓素受体激动剂U-46619、前列腺素F2α(PGF2α)、血管紧张素II、高钾或内皮素在去内皮的大鼠主动脉中诱导的收缩。(-)-地离散明也未改变大鼠胸主动脉中的环磷酸腺苷(cAMP)或环磷酸鸟苷(cGMP)含量。7. (-)-地离散明(30μM)不影响组胺、白三烯C4或卡巴胆碱在豚鼠气管中引起的收缩。(-)-地离散明也不阻断异丙肾上腺素在大鼠右心房和豚鼠气管中诱导的β1-或β2-肾上腺素能受体介导的反应。8. 在大鼠心室单个肌细胞中进行的电压钳研究表明,内向钠电流、慢内向钙电流或瞬时(ItO)和稳态(I800)外向电流不受(-)-地离散明(30μM)影响。9. 得出结论:(-)-地离散明是血管平滑肌中的一种选择性α-肾上腺素能受体和5-羟色胺受体拮抗剂。

相似文献

引用本文的文献

本文引用的文献

9
Receptor mechanisms for 5-hydroxytryptamine in rabbit arteries.兔动脉中5-羟色胺的受体机制。
Br J Pharmacol. 1981 Nov;74(3):619-26. doi: 10.1111/j.1476-5381.1981.tb10472.x.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验